Bone health: Quality versus quantity
- PMID: 40433261
- PMCID: PMC12088120
- DOI: 10.1016/j.jposna.2024.100054
Bone health: Quality versus quantity
Erratum in
-
Erratum Regarding Missing Patient Consent Statements in Previously Published Articles.J Pediatr Soc North Am. 2024 Sep 9;8:100102. doi: 10.1016/j.jposna.2024.100102. eCollection 2024 Aug. J Pediatr Soc North Am. 2024. PMID: 40433013 Free PMC article.
Abstract
Healthy bone has the ability to resist deformation and fracture while adapting to applied mechanical loads. These properties of bone depend on characteristics of its extracellular matrix. This review focuses on the contribution of bone quality and quantity to bone health and highlights current and promising future clinical approaches to measure bone health in the pediatric population. Bone's unique material properties are derived from its highly organized, hierarchical composite structure, together with its modeling and remodeling dynamics and microdamage mechanisms. Pediatric bone diseases and disorders affect the biological processes that regulate its quality, negatively impacting the extracellular matrix and causing bone fragility. Laboratory bone analysis from human biopsies or animal models of human bone diseases allows high detail examination of the mechanisms contributing to bone fragility. Conversely, clinical measurements of bone fragility are difficult and limited due to the inaccessibility of the material. Because bone quality directly affects fracture resistance, both structure and composition should be used in fracture risk calculation rather than bone mineral density or bone quantity alone. Thus, to advance clinical evaluation of bone fragility, future studies are needed to determine which characteristics of bone quality can be applied to clinical practice to predict bone fragility. New and effective clinical tools are needed to predict fracture risk taking bone quality into consideration.
Key concepts: (1)Bone quality and bone quantity are both fundamental for resistance to deformity and fracture.(2)Pediatric bone diseases and disorders alter bone's composition and structure, compromising bone quality and increasing vulnerability to fracture.(3)Current clinical approaches to assess bone fragility and fracture risk rely mainly on bone quantity measurements from DEXA scans.(4)DEXA bone mineral density poorly correlates with bone's resistance to fracture, both in adults and children.(5)Future clinical approaches to measure bone health should account for bone quality in order to predict fracture risk.
Keywords: Bone; Fragility; Health; Quality; Quantity.
© 2024 The Author(s).
Conflict of interest statement
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Alessandra Carriero reports financial support was provided by National Science Foundation. Alessandra Carriero reports financial support was provided by Human Frontier Science Program. Alessandra Carriero reports a relationship with Fellows of Politecnico di Milano, US that includes: board membership. Alessandra Carriero reports a relationship with the American Society of Bone and Mineral Research that includes: member of the Finance Committee. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
References
-
- Ritchie R.O. The conflicts between strength and toughness. Nat Mater. 2011;10(11):817–822. - PubMed
-
- Muñoz A., Docaj A., Ugarteburu M., Carriero A. Poor bone matrix quality: what can be done about it? Curr Osteoporos Rep. 2021;19(5):510–531. - PubMed
-
- Carriero A., Zavatsky A., Stebbins J., Theologis T., Shefelbine S.J. Correlation between lower limb bone morphology and gait characteristics in children with spastic diplegic cerebral palsy. J Pedia Orthop. 2009;29(1):73–79. - PubMed
-
- Kłosowski M.M., Carzaniga R., Abellan P., Ramasse Q., McComb D.W., Porter A.E., et al. Electron microscopy reveals structural and chemical changes at the nanometer scale in the osteogenesis imperfecta murine pathology. ACS Biomater Sci Eng. 2017;3(11):2788–2797. - PubMed
-
- Riggs B.L., Melton L., III, O'fallon W. Drug therapy for vertebral fractures in osteoporosis: evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy. Bone. 1996;18(3):S197–S201. - PubMed
LinkOut - more resources
Full Text Sources
